While both analyses are in agreement with our in vitro and in vivo studies and showed that low STING is associated with worse outcome, quantitative immunofluorescence of primary tumors specified that reduced STING expression in tumor cells is associated with tumor progression. This evidence concerns the gene STING1 and neoplasm.